000 01635cam a2200409 a 4500
001 3947787
003 OSt
005 20160504184055.0
008 891023s1989 ne a b 110 0 eng c
010 _a 89011675
020 _a0444811028 (Elsevier Science Pub. Co.)
035 _a(OCoLC)19741887
035 _a(OCoLC)ocm19741887
035 _a(CStRLIN)NYCM89-B5538
035 _a(NNC)3947787
040 _aDNLM/DLC
_cDLC
_dNNC-M
050 0 _aRC591
_b.G55 1989
060 _aW1 CU786M no. 52
_aWF 553 G567 1988
082 0 _a616.2/38061
_220
245 0 0 _aGlucocorticoids and mechanisms of asthma :
_bclinical and experimental aspects : proceedings of a symposium in Toronto, 18-19 November 1988 /
_ceditors, F.E. Hargreave ... [et al.].
260 _aAmsterdam ;
_aPrinceton :
_bExcerpta Medica ;
_aNew York, NY :
_bSole distributors for the USA and Canada, Elsevier Science Pub. Co.,
_c1989.
300 _axi, 276 p. :
_bill. ;
_c25 cm.
490 1 _aCurrent clinical practice series ;
_v52
500 _aSymposium and proceedings dedicated to John H. Toogood.
504 _aIncludes bibliographical references.
600 1 0 _aToogood, John H.
_vCongresses.
_9996
650 0 _aAsthma
_xHormone therapy
_vCongresses.
_9997
650 0 _aGlucocorticoids
_xTherapeutic use
_xTesting
_vCongresses.
_9998
650 2 _aAsthma
_xdrug therapy.
_9999
650 2 _aGlucocorticoids
_xtherapeutic use.
_91000
655 7 _aCongresses.
_2mesh
_91001
700 1 _aHargreave, Frederick E.
_91002
700 1 _aToogood, John H.
_91003
830 0 _aCurrent clinical practice series ;
_v52.
_91004
942 _2ddc
_cTBOOK
999 _c3016
_d3016